Blue Cross Blue Shield Michigan vs. University of Michigan Health: Contract Negotiation Impasse
Negotiations between Blue Cross Blue Shield of Michigan and the University of Michigan Health system have stalled, potentially moving 300,000 patients out-of-network as of July 1. Blue Cross, alongside Blue Care Network, has begun informing members that patients in southeast Michigan might need a new healthcare provider if no agreement is reached by the end of June.
Despite this, plans such as Medicare Advantage, Medicaid, and the University of Michigan employee plans are expected to remain unaffected. Blue Cross contends that a 44% price hike from Michigan Medicine is untenable. Andy Hetzel, vice president of corporate communications at Blue Cross, highlighted that rising healthcare costs drive insurance premiums higher. "We are committed to ensuring affordable and responsible payment to the Michigan Medicine system," he stated.
Conversely, Michigan Medicine claims Blue Cross has proposed a 30% reduction in reimbursement rates, which they deem unsustainable. They argue that their current reimbursement from Blue Cross is already 22% below other top commercial plans in Michigan. Dr. David Miller, CEO of Michigan Medicine, emphasized the need for an agreement to maintain high-quality, accessible care statewide and expressed a desire to partner with Blue Cross for future access assurance.
According to Blue Cross, patients identified under federal law as "continuing care patients" are granted a 90-day period post-service to stay in-network. Coverage for emergency services will vary, with a preference for in-network facilities recommended for both emergency and non-emergency care.
The impasse affects 16 Michigan Medicine facilities, including University Hospital and C.S. Mott Children’s Hospital. However, Sparrow Health in Lansing and Metro Health in Grand Rapids remain within the network.
This contract dispute occurs amidst broader healthcare cost challenges. Federal Medicaid and Affordable Care Act adjustments, combined with increasing insurance premiums, are placing additional strain on healthcare coverage. Additionally, Michigan’s healthcare market is facing reduced competition and rising costs due to insurer retrenchment and hospital consolidation.
Blue Cross recently reported a $246 million loss for 2025, attributing the rise to medical and pharmacy services expenses. In contrast, Michigan Medicine posted a nearly $234 million operating income for the same period, fueling its expansion plans across numerous outpatient locations in the state. The situation reflects broader issues of healthcare cost management and access, impacting industry operations and strategic planning in Michigan's healthcare insurance market.